$NROM
NOBLE ROMANS INC Stock $nrom

$nrom Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000165495423004699 Filed on April 13, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$3.308M	$3.329M	$14.45M
YoY Change	-4.54%	92529.38%	4.09%
Cost Of Revenue	$1.168M	$3.042M	$11.41M
YoY Change	-55.98%	8.84%	20.05%
Gross Profit	$2.140M	$286.7K	$3.046M
YoY Change	163.42%	-64.1%	-30.51%
Gross Profit Margin	64.7%	8.61%	21.08%
Selling, General & Admin	$518.8K	$569.0K	$2.168M
YoY Change	-4.01%	12.83%	21.05%
% of Gross Profit	24.24%	198.48%	71.17%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$201.3K	$235.9K	$943.0K
YoY Change	-14.29%	-54.82%	-29.1%
% of Gross Profit	9.4%	82.3%	30.96%
Operating Expenses	$1.168M	$681.6K	$11.41M
YoY Change	78.74%	-24.62%	20.05%
Operating Profit	$1.526M	-$394.9K	$427.7K
YoY Change	858.73%	372428.3%	-75.47%
Interest Expense	$383.3K	-$558.6K	$1.626M
YoY Change	12.11%	61.73%	19.43%
% of Operating Profit	25.12%		380.21%
Other Income/Expense, Net			$0.00
YoY Change
Pretax Income	$1.142M	-$953.5K	-$1.199M
YoY Change	-725.19%	211316.85%	-413.78%
Income Tax	$274.2K	-$80.52K	-$142.4K
% Of Pretax Income	24.0%
Net Earnings	$868.3K	-$873.0K	-$1.056M
YoY Change	-735.18%	269335.19%	-307.29%
Net Earnings / Revenue	26.25%	-26.22%	-7.31%
Basic Earnings Per Share	$0.04		-$0.05
Diluted Earnings Per Share	$0.04	-$0.04	-$0.05
COMMON SHARES
Basic Shares Outstanding	22.22M shares	22.22M shares	22.22M shares
Diluted Shares Outstanding	23.63M shares		23.51M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$463.3K	$785.5K	$785.5K
YoY Change	-42.66%	-37.83%	-37.83%
Cash & Equivalents	$463.3K	$785.5K
Short-Term Investments
Other Short-Term Assets	$401.4K	$424.8K	$424.8K
YoY Change	-9.11%	2.29%	2.29%
Inventory	$1.007M	$997.9K	$997.9K
Prepaid Expenses	$401.4K	$424.8K
Receivables	$377.6K	$350.2K	$824.1K
Other Receivables	$1.460M	$0.00	$0.00
Total Short-Term Assets	$4.183M	$3.032M	$3.032M
YoY Change	33.37%	-15.24%	-15.24%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.631M	$4.713M	$10.37M
YoY Change	-59.12%	-8.48%	-6.99%
Goodwill	$278.5K	$278.5K
YoY Change		0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$4.044M	$4.309M	$4.309M
YoY Change	934.72%	1228.25%	6.59%
Total Long-Term Assets	$14.82M	$15.31M	$15.31M
YoY Change	-8.14%	-3.09%	-3.09%
TOTAL ASSETS
Total Short-Term Assets	$4.183M	$3.032M	$3.032M
Total Long-Term Assets	$14.82M	$15.31M	$15.31M
Total Assets	$19.00M	$18.34M	$18.34M
YoY Change	-1.38%	-5.33%	-5.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$598.8K	$650.6K	$650.6K
YoY Change	-1.45%	-29.22%	-29.22%
Accrued Expenses	$799.2K	$799.2K	$799.2K
YoY Change	19.49%	21.8%	21.8%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.000M	$866.7K	$866.7K
YoY Change
Total Short-Term Liabilities	$2.398M	$2.316M	$2.316M
YoY Change	87.87%	47.05%	47.05%
LONG-TERM LIABILITIES
Long-Term Debt	$7.956M	$8.094M	$8.094M
YoY Change	-7.6%	-4.74%	-4.74%
Other Long-Term Liabilities	$5.903M	$6.066M	$6.066M
YoY Change	-10.72%	-5.36%	-5.36%
Total Long-Term Liabilities	$13.86M	$14.16M	$14.16M
YoY Change	-8.96%	-5.0%	-5.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.398M	$2.316M	$2.316M
Total Long-Term Liabilities	$13.86M	$14.16M	$14.16M
Total Liabilities	$16.26M	$16.48M	$16.48M
YoY Change	-1.46%	-0.03%	-0.03%
SHAREHOLDERS EQUITY
Retained Earnings	-$22.08M	-$22.95M
YoY Change		4.82%
Common Stock	$24.83M	$24.82M
YoY Change		0.11%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.741M	$1.867M	$1.867M
YoY Change
Total Liabilities & Shareholders Equity	$19.00M	$18.34M	$18.34M
YoY Change	-1.38%	-5.33%	-5.33%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	$868.3K	-$873.0K	-$1.056M
YoY Change	-735.18%	269335.19%	-307.29%
Depreciation, Depletion And Amortization	$201.3K	$235.9K	$943.0K
YoY Change	-14.29%	-54.82%	-29.1%
Cash From Operating Activities	-$192.2K	$6.640K	$29.58K
YoY Change	-1870.79%	-98.14%	-98.05%
INVESTING ACTIVITIES
Capital Expenditures	$13.34K	-$35.89K	$507.6K
YoY Change	-97.14%	-95.94%	-64.99%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$13.34K	$35.89K	-$507.6K
YoY Change	-97.14%	-104.06%	-64.99%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$116.7K	0.000	$0.00
YoY Change
NET CHANGE
Cash From Operating Activities	-$192.2K	6.640K	$29.58K
Cash From Investing Activities	-$13.34K	35.89K	-$507.6K
Cash From Financing Activities	-$116.7K	0.000	$0.00
Net Change In Cash	-$322.2K	42.53K	-$478.0K
YoY Change	-29.26%	-108.09%	-791.24%
FREE CASH FLOW
Cash From Operating Activities	-$192.2K	$6.640K	$29.58K
Capital Expenditures	$13.34K	-$35.89K	$507.6K
Free Cash Flow	-$205.6K	$42.53K	-$478.0K
YoY Change	-54.87%	-96.57%	-791.24%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	3232406	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	3374841	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	324402	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	350189	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1518929	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	29584	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1449779	usd
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2084710	usd
CY2022	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	258000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1575303	usd
CY2021Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	597229	usd
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	14905890	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	24791568	usd
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0000709005
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0.00
CY2021Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0.00
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	40000000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	22215512	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	22215512	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	22215512	shares
CY2020Q4	us-gaap	Goodwill Goodwill	278466	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3334167	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3643667	shares
CY2021	nrom	Non Vested Stock Options Outstanding Beggining NonVestedStockOptionsOutstandingBeggining	962336	shares
CY2022Q4	nrom	Convertible Note Common Stock Price Per Shares ConvertibleNoteCommonStockPricePerShares	0.50
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	0.66
CY2022	nrom	Maturity Date MaturityDate	February 2023
CY2022	nrom	Additional Expense For Rent AdditionalExpenseForRent	18553	usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	0-11104
CY2022	dei	Entity Registrant Name EntityRegistrantName	NOBLE ROMAN’S, INC.
CY2022	dei	Local Phone Number LocalPhoneNumber	634-3377
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	IN
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	35-1281154
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	6612 E
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	75th Street
CY2022	dei	Entity Address Address Line3 EntityAddressAddressLine3	Suite 450
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Indianapolis
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	IN
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	46250
CY2022	dei	City Area Code CityAreaCode	317
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-22953074	usd
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	3400000	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	22215512	shares
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	785522	usd
CY2021Q4	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	904474	usd
CY2022Q4	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	824091	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	994085	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	997868	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	415309	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	424822	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	3577381	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	3032303	usd
CY2021Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	4216246	usd
CY2022Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	4351558	usd
CY2021Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	3065644	usd
CY2022Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	3116030	usd
CY2021Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	235051	usd
CY2022Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	63097	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7530685	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2817477	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4713208	usd
CY2022Q4	us-gaap	Deferred Costs DeferredCosts	934036	usd
CY2022Q4	us-gaap	Goodwill Goodwill	278466	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5660155	usd
CY2022Q4	us-gaap	Assets Assets	18343198	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	650582	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	799164	usd
CY2021Q4	nrom	Current Portion Of Corbel Loan Payable CurrentPortionOfCorbelLoanPayable	0	usd
CY2022Q4	nrom	Current Portion Of Corbel Loan Payable CurrentPortionOfCorbelLoanPayable	866667	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2316413	usd
CY2021Q4	us-gaap	Long Term Loans From Bank LongTermLoansFromBank	7898941	usd
CY2022Q4	us-gaap	Long Term Loans From Bank LongTermLoansFromBank	7470900	usd
CY2021Q4	nrom	Corbel Warrant Value CorbelWarrantValue	29037	usd
CY2022Q4	nrom	Corbel Warrant Value CorbelWarrantValue	29037	usd
CY2022Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	622864	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5570639	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5103286	usd
CY2021Q4	us-gaap	Deferred Revenue And Credits Noncurrent DeferredRevenueAndCreditsNoncurrent	810044	usd
CY2022Q4	us-gaap	Deferred Revenue And Credits Noncurrent DeferredRevenueAndCreditsNoncurrent	934036	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	14160123	usd
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	40000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	22215512	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	24819736	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-21897004	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	2894564	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1866662	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	19375757	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	18343198	usd
CY2020	nrom	Restaurant Revenue Company Owned Restaurants RestaurantRevenueCompanyOwnedRestaurants	6209279	usd
CY2021	nrom	Restaurant Revenue Company Owned Restaurants RestaurantRevenueCompanyOwnedRestaurants	8939569	usd
CY2022	nrom	Restaurant Revenue Company Owned Restaurants RestaurantRevenueCompanyOwnedRestaurants	9704169	usd
CY2021	nrom	Restaurant Revenue Company Owned Non Traditional RestaurantRevenueCompanyOwnedNonTraditional	485595	usd
CY2022	nrom	Restaurant Revenue Company Owned Non Traditional RestaurantRevenueCompanyOwnedNonTraditional	712517	usd
CY2022	nrom	Revenue Recognition Services Franchise RevenueRecognitionServicesFranchise	4002824	usd
CY2020	nrom	Restaurant Expenses Company Owned Restaurants RestaurantExpensesCompanyOwnedRestaurants	4938133	usd
CY2020	nrom	Restaurant Expenses Company Owned Non Traditional RestaurantExpensesCompanyOwnedNonTraditional	447040	usd
CY2021	nrom	Restaurant Expenses Company Owned Non Traditional RestaurantExpensesCompanyOwnedNonTraditional	466469	usd
CY2020	nrom	Franchising Expenses FranchisingExpenses	1736870	usd
CY2021	nrom	Franchising Expenses FranchisingExpenses	1810363	usd
CY2022	nrom	Franchising Expenses FranchisingExpenses	2185751	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	11406821	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	848913	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	450550	usd
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1717209	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1790722	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2167678	usd
CY2020	nrom	Non Operating Expenses NonOperatingExpenses	9221620	usd
CY2021	nrom	Non Operating Expenses NonOperatingExpenses	12141300	usd
CY2022	nrom	Non Operating Expenses NonOperatingExpenses	14025049	usd
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	2314044	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	1743588	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	427716	usd
CY2020	us-gaap	Interest Expense InterestExpense	1914344	usd
CY2021	us-gaap	Interest Expense InterestExpense	1361625	usd
CY2022	us-gaap	Interest Expense InterestExpense	1626221	usd
CY2020	nrom	Adjust Valuation Of Receivables AdjustValuationOfReceivables	4941718	usd
CY2021	nrom	Adjust Valuation Of Receivables AdjustValuationOfReceivables	0	usd
CY2022	nrom	Adjust Valuation Of Receivables AdjustValuationOfReceivables	0	usd
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-4542018	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	381963	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-1198505	usd
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	839928	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-127502	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-142435	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-5381946	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	509465	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1056070	usd
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.24
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22215512	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22215512	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22215512	shares
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.24
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23465512	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23641678	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23512550	shares
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	7833788	usd
CY2020	nrom	Write Off Unamortized Closing To Sub Debt That Was Converted Amount WriteOffUnamortizedClosingToSubDebtThatWasConvertedAmount	-116400	usd
CY2020	nrom	Amortization Of Value Of Stock Options Amount AmortizationOfValueOfStockOptionsAmount	21536	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	2356978	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	509465	usd
CY2021	nrom	Amortization Of Value Of Stock Options Amount AmortizationOfValueOfStockOptionsAmount	28121	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	2894564	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1056070	usd
CY2022	nrom	Amortization Of Value Of Stock Options AmortizationOfValueOfStockOptions	28168	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1866662	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-5381946	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	509465	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1056070	usd
CY2020	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	1433295	usd
CY2021	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	1330017	usd
CY2022	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	942977	usd
CY2020	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	46994	usd
CY2021	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	36223	usd
CY2022	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	18552	usd
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	839928	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-127502	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-142435	usd
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-98388	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-24971	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	80384	usd
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-9896	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-103530	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-3783	usd
CY2020	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	189884	usd
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-19391	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-9514	usd
CY2020	us-gaap	Increase Decrease In Accounts Receivable And Other Operating Assets IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets	4508836	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable And Other Operating Assets IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets	-122440	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable And Other Operating Assets IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets	122804	usd
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	147040	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	41058	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	76669	usd
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1675747	usd
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2084710	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	507575	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1449779	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-507575	usd
CY2020	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	4379024	usd
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	0	usd
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	0	usd
CY2020	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	1275000	usd
CY2021	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	usd
CY2022	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	usd
CY2020	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	7039218	usd
CY2021	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	0	usd
CY2022	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	0	usd
CY2020	nrom	Lease Liabilities LeaseLiabilities	0	usd
CY2021	nrom	Lease Liabilities LeaseLiabilities	0	usd
CY2022	nrom	Lease Liabilities LeaseLiabilities	0	usd
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1385194	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	usd
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	976231	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	69150	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-477991	usd
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	218132	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1194363	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1263513	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1194363	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1263513	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	785522	usd
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23641678	shares
CY2021	us-gaap	Earnings Per Share Diluted Distributed EarningsPerShareDilutedDistributed	0.02
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1056070	usd
CY2022	nrom	Weighted Average Number Of Common Shares Outstanding Basic WeightedAverageNumberOfCommonSharesOutstandingBasic	22215512	shares
CY2022	nrom	Earnings Loss Per Share Basic EarningsLossPerShareBasic	-0.05
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Use of Estimates: The preparation of the consolidated financial statements in conformity with United States generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates. After a thorough review by management in 2018, the Company permanently wrote off $1.3 million and created an additional reserve for possible non-collection of $2.8 million. After a review in 2019 and also considering the impact of the COVID-19 pandemic, it was decided to add an additional reserve of $1.3 million for possible non-collections. In 2020, in light of the additional uncertainty created as a result of the COVID-19 pandemic, the Company decided to create a reserve for uncollectability on all long-term franchisee receivables. The Company will continue to pursue collection where circumstances are appropriate and all collections of these receivables in the future will result in additional income at the time received. The Company evaluates its property and equipment and related costs periodically to assess whether any impairment indications are present, including recurring operating losses and significant adverse changes in legal factors or business climate that affect the recovery of recorded value. If any impairment of an individual asset is evident, a loss would be provided to reduce the carrying value to its estimated fair value.</p>
CY2022	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	130000	usd
CY2022Q4	nrom	Additional Reserve For Noncollection AdditionalReserveForNoncollection	280000	usd
CY2022Q4	nrom	Additional Reserve AdditionalReserve	130000	usd
CY2022Q4	us-gaap	Debt Issuance Costs Line Of Credit Arrangements Net DebtIssuanceCostsLineOfCreditArrangementsNet	371920	usd
CY2022	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-993570	usd
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23512550	shares
CY2022	us-gaap	Earnings Per Share Diluted Distributed EarningsPerShareDilutedDistributed	0.04
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	622864	usd
CY2019	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	1422960	usd
CY2019	nrom	Additional Tax Expense AdditionalTaxExpense	400000	usd
CY2020	nrom	Additional Tax Expense AdditionalTaxExpense	267528	usd
CY2020	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	572400	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	3200000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	3500000	usd
CY2022	us-gaap	Taxes And Licenses TaxesAndLicenses	142135	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-5381946	usd
CY2020	nrom	Weighted Average Number Of Common Shares Outstanding Basic WeightedAverageNumberOfCommonSharesOutstandingBasic	22215512	shares
CY2020	nrom	Earnings Loss Per Share Basic EarningsLossPerShareBasic	-0.24
CY2020	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-5319446	usd
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23465512	shares
CY2020	us-gaap	Earnings Per Share Diluted Distributed EarningsPerShareDilutedDistributed	0.24
CY2021	us-gaap	Net Income Loss NetIncomeLoss	509465	usd
CY2021	nrom	Weighted Average Number Of Common Shares Outstanding Basic WeightedAverageNumberOfCommonSharesOutstandingBasic	22215512	shares
CY2021	nrom	Earnings Loss Per Share Basic EarningsLossPerShareBasic	0.02
CY2021	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-571965	usd
CY2022	nrom	Discription Discription	tax credit was equal to 50% of the qualified wages an eligible employer paid to employees after March 12, 2020 and before January 1, 2021. The credit was also limited to a maximum annual per employee credit of $5,000. The credit was then extended through June 30, 2021 by the Tax Payer Certainty and Disaster Relief Act (“Relief Act”) (Division EE of the Consolidated Appropriations Act). The Relief Act modified the credit to be 70% of up to $10,000 of qualified wages per quarter in 2021 through June 30, 2021
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	1718000	usd
CY2021Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	171800	usd
CY2020Q1	nrom	Note Payable Principle Value NotePayablePrincipleValue	8000000.0	usd
CY2022Q4	nrom	Line Of Credit Principal LineOfCreditPrincipal	8736388	usd
CY2022Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	369784	usd
CY2022Q4	us-gaap	Line Of Credit LineOfCredit	8367604	usd
CY2022	nrom	Description Of Warrant Price DescriptionOfWarrantPrice	In the fourth quarter of 2016, the Company issued 32 Units, for a purchase price of $50,000 per Unit, or $1,600,000 in the aggregate and, in January 2017, the Company issued another 16 Units, or an additional $800,000 in the aggregate. Each $50,000 Unit consisted of a convertible, subordinated, unsecured promissory note (the “Notes”) in an aggregate principal amount of $50,000 and warrants (the “Warrants”) to purchase up to 50,000 shares of the Company’s Common Stock, no par value per share. The Company issued Units to investors including the following related parties: Paul W. Mobley, the Company’s Executive Chairman, Chief Financial Officer and a director of the Company ($150,000); and Herbst Capital Management, LLC, the principal of which is Marcel Herbst, a director of the Company ($200,000).
CY2022	nrom	Description Of Interest On Accrued Notes DescriptionOfInterestOnAccruedNotes	the Company offered to extend the maturity of the Notes and the expiration date of the Warrants to January 2023. Certain of the holders of the Notes and Warrants accepted the Company’s offer. Accordingly, of the principal amount of the Notes, holders of $775,000 in principal amount extended their Notes until January 31, 2023. In 2018 and 2019, holders of $500,000 in principal amount of the Notes converted those Notes to 1,000,000 shares of the Company’s Common Stock in accordance with the terms of the Note. In February 2020, in conjunction with the Company’s refinancing of its debt, $1,275,000 in principal amount of those Notes was repaid leaving a balance of $625,000 which mature on January 31, 2023. The holders of the remaining $625,000 principal amount of Notes can elect, at their option any time prior to maturity, convert those Notes to Common Stock in accordance with the terms of the Notes.
CY2023Q1	nrom	Note Payable Principle Amount NotePayablePrincipleAmount	775000	usd
CY2020Q1	nrom	Description Of Warrant Price DescriptionOfWarrantPrice	Warrants at a price of $0.001 per share of Common Stock subject to the Warrant upon 30 days’ notice if the daily average weighted trading price of the Common Stock equals or exceeds $2.00 per share for a period of 30 consecutive trading days.
CY2022Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	625000	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	2136	usd
CY2022	us-gaap	Revenue Recognition Services Royalty Fees RevenueRecognitionServicesRoyaltyFees	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 4: Royalties and Fees</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Approximately $198,000, $204,000 and $293,500 are included in 2020, 2021 and 2022, respectively, royalties and fees in the Consolidated Statements of Operations for amortized initial franchise fees. Also included in royalties and fees were approximately $45,000, $32,000 and $61,000 in 2020, 2021 and 2022, respectively, for equipment commissions. Most of the cost for the services required to be performed by the Company are incurred prior to the franchise fee income being recorded which is based on contractual liability for the franchisee. Such incremental costs, include training, design and related travel cost to new franchises. The deferred contract income and costs approximated $810,000 on December 31, 2021 and $934,000 on December 31, 2022.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In conjunction with the development of Noble Roman’s Pizza and Tuscano’s Italian Style Subs, the Company has devised its own recipes for many of the ingredients that go into the making of its products (“Proprietary Products”). The Company contracts with various manufacturers to manufacture its Proprietary Products in accordance with the Company’s recipes and formulas and to sell those products to authorized distributors at a contract price which includes an allowance for use of the Company’s recipes. The manufacturing contracts also require the manufacturers to hold those allowances in trust and to remit those allowances to the Company on a periodic basis, usually monthly. The Company recognizes those allowances in revenue as earned based on sales reports from the distributors.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the 12-month period ended December 31, 2022 there were no company-operated or franchised Craft Pizza & Pub restaurants opened or closed. During the same twelve-month period there were 31 new non-traditional outlets opened and seven non-traditional outlets closed.</p>
CY2021Q4	nrom	Deferred Contract Income And Costs DeferredContractIncomeAndCosts	810000	usd
CY2022Q4	nrom	Deferred Contract Income And Costs DeferredContractIncomeAndCosts	934000	usd
CY2022Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	153100	usd
CY2022Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	1600000	usd
CY2022Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	111500	usd
CY2022Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	16100	usd
CY2022Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	95300000000	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.07	pure
CY2022	nrom	Weighted Average Lease Term WeightedAverageLeaseTerm	P7Y3M18D
CY2022	us-gaap	Lease Cost LeaseCost	18775	usd
CY2021Q4	nrom	Deferred Tax Asset DeferredTaxAsset	3200000	usd
CY2022Q4	nrom	Deferred Tax Asset DeferredTaxAsset	3400000	usd
CY2022	us-gaap	Gain Loss On Sale Of Leased Assets Net Operating Leases GainLossOnSaleOfLeasedAssetsNetOperatingLeases	1260000	usd
CY2021Q4	nrom	Outstanding Principal Balance OutstandingPrincipalBalance	625000	usd
CY2021Q4	nrom	Convertible Note Common Stock Price Per Shares ConvertibleNoteCommonStockPricePerShares	0.50
CY2022	nrom	Warrants Purchase Shares WarrantsPurchaseShares	775000	shares
CY2022Q4	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.57
CY2021	nrom	Warrants Purchase Shares WarrantsPurchaseShares	150000	shares
CY2022	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	2250000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	4141167	shares
CY2021	nrom	Tax Benefit TaxBenefit	6861	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	28168	usd
CY2022	nrom	Tax Benefit TaxBenefit	6873	usd
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	26106	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.20	pure
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0168	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0282	pure
CY2020	nrom	Stock Options Outstanding Begining StockOptionsOutstandingBegining	3978167	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	443500	shares
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4421667	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	463500	shares
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	30000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4855167	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	520000	shares
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	59000	shares
CY2022	nrom	Stock Options Outstanding Begining StockOptionsOutstandingBegining	5316167	shares
CY2020	nrom	Non Vested Stock Options Outstanding Beggining NonVestedStockOptionsOutstandingBeggining	731336	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	443500	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	212500	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	0	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	962336	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	463500	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	354336	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	30000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1041500	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	520000	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	327500	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	59000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1175000	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.40
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.70
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.22
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	21536	usd
CY2020	nrom	Tax Benefit TaxBenefit	5168	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	28119	usd
CY2022	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P36M
CY2022Q4	nrom	Warrant Purchase Shares WarrantPurchaseShares	50000	shares
CY2022Q4	nrom	Aggregate Principal Amount Of Note Payable AggregatePrincipalAmountOfNotePayable	50000	usd
CY2022	dei	Auditor Name AuditorName	Somerset CPA’s, P.C.
CY2022	dei	Auditor Location AuditorLocation	Indianapolis, Indiana
CY2022	dei	Auditor Firm AuditorFirmId	752

Files In Submission

Name	View Source	Status
0001654954-23-004699-index-headers.html	Edgar Link	pending
0001654954-23-004699-index.html	Edgar Link	pending
0001654954-23-004699.txt	Edgar Link	pending
0001654954-23-004699-xbrl.zip	Edgar Link	pending
btbd_10k.htm	Edgar Link	pending
btbd_10k_htm.xml	Edgar Link	completed
btbd_ex311.htm	Edgar Link	pending
btbd_ex312.htm	Edgar Link	pending
btbd_ex321.htm	Edgar Link	pending
btbd_ex322.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nrom-20221231.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
nrom-20221231_cal.xml	Edgar Link	unprocessable
nrom-20221231_pre.xml	Edgar Link	unprocessable
nrom-20221231_def.xml	Edgar Link	unprocessable
nrom-20221231_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NROM
NOBLE ROMANS INC Stock $nrom

2023 Q1 Form 10-K Financial Statement

#000165495423004699 Filed on April 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NROM NOBLE ROMANS INC Stock $nrom

2023 Q1 Form 10-K Financial Statement

#000165495423004699 Filed on April 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NROM
NOBLE ROMANS INC Stock $nrom